JPS5414096B1 - - Google Patents

Info

Publication number
JPS5414096B1
JPS5414096B1 JP8630073A JP8630073A JPS5414096B1 JP S5414096 B1 JPS5414096 B1 JP S5414096B1 JP 8630073 A JP8630073 A JP 8630073A JP 8630073 A JP8630073 A JP 8630073A JP S5414096 B1 JPS5414096 B1 JP S5414096B1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8630073A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5414096B1 publication Critical patent/JPS5414096B1/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyridine Compounds (AREA)
JP8630073A 1969-04-01 1973-07-31 Pending JPS5414096B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81237069A 1969-04-01 1969-04-01

Publications (1)

Publication Number Publication Date
JPS5414096B1 true JPS5414096B1 (pl) 1979-06-05

Family

ID=25209368

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2779370A Pending JPS5314544B1 (pl) 1969-04-01 1970-04-01
JP8630073A Pending JPS5414096B1 (pl) 1969-04-01 1973-07-31

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2779370A Pending JPS5314544B1 (pl) 1969-04-01 1970-04-01

Country Status (17)

Country Link
JP (2) JPS5314544B1 (pl)
AT (1) AT300762B (pl)
BE (1) BE748178A (pl)
CH (1) CH522589A (pl)
DE (1) DE2015573C3 (pl)
DK (1) DK131459B (pl)
ES (1) ES378092A1 (pl)
FI (1) FI54796C (pl)
FR (1) FR2042295B1 (pl)
GB (1) GB1298771A (pl)
IE (1) IE34583B1 (pl)
IL (2) IL42029A (pl)
NL (1) NL171155C (pl)
NO (1) NO129903B (pl)
PH (2) PH9407A (pl)
SE (2) SE381039B (pl)
ZA (1) ZA702065B (pl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138581A (en) 1969-04-01 1979-02-06 Sterling Drugs Inc. 3(Hydroxy or hydroxymethyl)-4(hydroxy)-α-(aminomethyl)benzyl alcohols
US3809714A (en) * 1972-08-31 1974-05-07 Interx Research Corp Novel ester of ((methylamino)methyl) benzyl alcohol
US3868461A (en) * 1972-11-22 1975-02-25 Interx Research Corp Ester of 3,4-dihydroxy-alpha (isopropylamino) methyl benzyl alcohol, composition and anti-asthma use thereof
US4046913A (en) 1973-08-18 1977-09-06 Boehringer Ingelheim Gmbh 1-(M-alkanoyloxy-phenyl)-1-hydroxy-2-(N-lower alkyl-amino)-ethanes and salts thereof
FR2315264A2 (fr) * 1974-01-15 1977-01-21 Klinge Co Chem Pharm Fab Phenolethanolamines acylees
US3957849A (en) * 1974-09-09 1976-05-18 Zoecon Corporation Cyclopropane esters
US4000315A (en) * 1974-09-09 1976-12-28 Zoecon Corporation Cyclopropane esters for the control of mites
EP0043807B1 (en) * 1980-07-09 1984-05-30 Aktiebolaget Draco 1-(dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates
EP0046144B1 (en) * 1980-07-09 1984-04-11 Aktiebolaget Draco Therapeutically active derivatives of phenylethanol amines
FR2541999B1 (fr) * 1983-03-04 1986-09-19 Bristol Myers Co Phenethanolamines et leurs utilisations
US4614830A (en) * 1985-08-09 1986-09-30 Sterling Drug Inc. Esterification process
IT1229846B (it) * 1989-04-20 1991-09-13 Simes Esteri di catecolammine.
US5118683A (en) * 1990-06-13 1992-06-02 Schering Corporation Esters of 4-hydroxy-1,3-benzenedimethanol and compositions and methods employing such compounds
US5011845A (en) * 1990-06-13 1991-04-30 Schering Corporation Cyclic diesters of 4-hydroxy-1,3-benzenedimethanol and compositions and methods employing such compounds
AU2010236404B2 (en) 2009-04-15 2016-11-03 Research Triangle Institute Monoamine reuptake inhibitors
AU2011255276B2 (en) 2010-05-21 2016-09-22 Research Triangle Institute Phenylmorpholines and analogues thereof
AU2011255456B2 (en) 2010-05-21 2017-01-19 Dignity Health Doing Business As St. Joseph's Hospital And Medical Center And Barrow Neurological Institute 1 - phenylmorpholine derivatives as hydroxybupropion analogues for treating drug dependence
US9784726B2 (en) 2013-01-08 2017-10-10 Atrogi Ab Screening method, a kit, a method of treatment and a compound for use in a method of treatment
CN108997261B (zh) * 2017-06-07 2022-01-07 东莞市凯法生物医药有限公司 一类化合物及其制备方法与应用
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses
WO2024153813A1 (en) 2023-01-20 2024-07-25 Atrogi Ab Beta 2-adrenergic receptor agonists for treatment or prevention of muscle wasting
GB202302225D0 (en) 2023-02-16 2023-04-05 Atrogi Ab New medical uses
GB202303229D0 (en) 2023-03-06 2023-04-19 Atrogi Ab New medical uses

Also Published As

Publication number Publication date
NL7004671A (pl) 1970-10-05
CH522589A (fr) 1972-06-30
IE34583B1 (en) 1975-06-25
PH14377A (en) 1981-06-17
FI54796C (fi) 1979-03-12
FR2042295B1 (pl) 1974-06-14
AT300762B (de) 1972-08-10
IL34148A0 (en) 1970-07-19
PH9407A (en) 1975-11-06
ES378092A1 (es) 1973-01-01
NL171155B (nl) 1982-09-16
JPS5314544B1 (pl) 1978-05-18
NO129903B (pl) 1974-06-10
NL171155C (nl) 1983-02-16
ZA702065B (en) 1971-01-27
BE748178A (fr) 1970-09-28
DE2015573B2 (de) 1978-03-16
DE2015573A1 (de) 1970-10-08
FR2042295A1 (pl) 1971-02-12
SE381039B (sv) 1975-11-24
DE2015573C3 (de) 1978-11-02
IL42029A (en) 1974-01-14
FI54796B (fi) 1978-11-30
IE34583L (en) 1970-10-01
GB1298771A (en) 1972-12-06
IL34148A (en) 1974-01-14
DK131459B (da) 1975-07-21
SE413503B (sv) 1980-06-02
DK131459C (pl) 1975-12-08

Similar Documents

Publication Publication Date Title
AU2270770A (pl)
AU465452B2 (pl)
AU429630B2 (pl)
AU450150B2 (pl)
AU2355770A (pl)
AU442375B2 (pl)
AU470301B1 (pl)
AU427401B2 (pl)
AU442463B2 (pl)
AU442380B2 (pl)
AU417208B2 (pl)
AU428129B2 (pl)
AU428131B2 (pl)
AU414607B2 (pl)
AU425297B2 (pl)
AU438128B2 (pl)
AT308690B (pl)
AU442285B2 (pl)
AU442322B2 (pl)
AU442357B2 (pl)
AU410358B2 (pl)
AU470661B1 (pl)
AU442554B2 (pl)
AU442535B2 (pl)
AU442538B2 (pl)